Age Matters: Key Contributors to Interferon Toxicity in Infants During Influenza Virus Infection

Area of Science:

• Neonatal immunology
• Respiratory viral infections
• Cytokine biology

Background:

• Neonatal immune responses rely on innate mechanisms, with interferons (IFNs) being crucial for antiviral defense.
• While IFNs are vital for controlling viral infections, emerging evidence suggests they may worsen disease in neonates.
• The neonatal lung's rapid development makes it particularly vulnerable to the detrimental effects of IFNs.

Purpose of the Study:

• To review the mechanisms by which interferons (IFNs) induce toxicity in the neonatal lung during respiratory viral infections.
• To explore potential therapeutic strategies to mitigate IFN-induced toxicity in neonates.

Main Methods:

• Literature review of recent studies on interferon function and toxicity in neonatal respiratory viral infections.
• Analysis of proposed mechanisms of IFN-induced lung pathogenesis in neonates.
• Identification of potential therapeutic targets for mitigating IFN toxicity.

Main Results:

• Interferons (IFNs), while antiviral, can impede cell proliferation and disrupt the pulmonary barrier in neonates.
• IFNs generate reactive oxygen species, contributing to lung damage in the context of influenza infection.
• These effects are particularly detrimental to the rapidly developing neonatal lung, suggesting a role in pathogenesis.

Conclusions:

• Interferon-induced toxicity is a significant factor in neonatal influenza pathogenesis.
• Understanding these mechanisms is crucial for developing targeted therapies to protect neonates from severe respiratory viral infections.
• Further research into mitigating IFN toxicity could improve outcomes for hospitalized infants.